{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:02:48Z","timestamp":1784264568598,"version":"3.55.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Health Popul Nutr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated fatty liver disease (MAFLD) is closely linked to metabolic abnormalities, including central obesity, dyslipidaemia, hypertension, hyperglycaemia, and impaired liver function. Identifying effective lifestyle interventions and reliable noninvasive biomarkers remains a public health priority.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to evaluate the effect of dietary modification on metabolic and hepatic parameters in women with MAFLD and to assess the potential role of interleukin-18 (IL-18) and alpha-2-macroglobulin (A2M) as noninvasive biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective interventional study was conducted on 54 women with obesity and at least one criterion of metabolic syndrome. Participants were categorized into mild MAFLD, moderate MAFLD, or healthy liver groups based on ultrasonographic findings. All participants followed a calorie-restricted, balanced diet (1000\u20131200\u00a0kcal\/day) for eight weeks. Anthropometric measurements, 24-hour dietary recall, and biochemical parameters, including IL-18, A2M, and liver enzymes, were assessed at baseline and post-intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At baseline, women with moderate MAFLD exhibited significantly higher body mass index (BMI), minimal waist circumference (MWC), low-density lipoprotein cholesterol (LDL-C), and LDL\/HDL ratio, along with lower high-density lipoprotein cholesterol (HDL-C), reflecting an adverse metabolic profile. They also reported higher macronutrient intake and lower dietary fiber consumption. A strong positive correlation between IL-18 and A2M (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2264\u20090.01) was observed across all groups and was associated with an unfavorable metabolic status.\u00a0Following the intervention, significant improvements (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2264\u20090.05) were observed in weight, BMI, MWC, LDL-C, and gamma-glutamyl transferase (GGT), along with increased HDL-C levels. A highly significant reduction (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2264\u20090.01) in IL-18 was observed only among participants with MAFLD, while A2M levels decreased significantly (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2264\u20090.05\u20130.01) across all groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Concluions<\/jats:title>\n                    <jats:p>A calorie-restricted, balanced diet significantly improves metabolic and hepatic parameters in women with MAFLD. These findings highlight the beneficial impact of dietary intervention on liver enzymes and inflammatory markers, particularly GGT, IL-18, and A2M, and support the potential utility of A2M as a noninvasive biomarker and therapeutic target.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41043-026-01324-8","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:34:15Z","timestamp":1778474055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of nutritional intervention on interleukin-18 and alpha-2-macroglobulin in women with obesity and metabolic dysfunction-associated fatty liver disease: a prospective cohort study"],"prefix":"10.1186","volume":"45","author":[{"given":"Salwa M.","family":"El Shebini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman R.","family":"Youness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihad H.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham A.","family":"Orban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha I. A.","family":"Moaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"issue":"1","key":"1324_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cld.2017.08.003","volume":"22","author":"CC Lindenmeyer","year":"2018","unstructured":"Lindenmeyer CC, McCulloug AJ. The natural history of nonalcoholic fatty liver disease-an evolving view. Clin Liver Dis. 2018;22(1):11\u201321. https:\/\/doi.org\/10.1016\/j.cld.2017.08.003.","journal-title":"Clin Liver Dis"},{"key":"1324_CR2","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. Nafld: a multisystem disease. J Hepatol. 2015;62:S47-64. https:\/\/doi.org\/10.1016\/j.jhep.2014.12.012.","journal-title":"J Hepatol"},{"issue":"1","key":"1324_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384. https:\/\/doi.org\/10.1002\/hep.28431.","journal-title":"Hepatology"},{"issue":"4","key":"1324_CR4","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/liv.15852","volume":"44","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Golabi P, Paik J, Owrangi S, Yilmaz Y, El-Kassas M, Alswat K, Alqahtani SA. Prevalence of metabolic dysfunction-associated fatty liver disease in the Middle East and North Africa. Liver Int. 2024;44(4):1061\u201370. https:\/\/doi.org\/10.1111\/liv.15852.","journal-title":"Liver Int"},{"issue":"1","key":"1324_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-022-00980-1","volume":"22","author":"S Pouwels","year":"2022","unstructured":"Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W, et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord. 2022;22(1):63. https:\/\/doi.org\/10.1186\/s12902-022-00980-1.","journal-title":"BMC Endocr Disord"},{"key":"1324_CR6","unstructured":"Smith J. 13 July (2023). A Liver Disease Gets a New Name, Diagnostic Criteria. Medscape. Retrieved 5 June 2024."},{"issue":"6","key":"1324_CR7","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520\/","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u201386. https:\/\/doi.org\/10.1097\/HEP.0000000000000520\/.","journal-title":"Hepatology"},{"issue":"10","key":"1324_CR8","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","volume":"22","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Golabi P, Price JK, Owrangi S, Gundu-Rao N, Satchi R, et al. The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes. Clin Gastroenterol Hepatol. 2024;22(10):1999\u20132010. https:\/\/doi.org\/10.1016\/j.cgh.2024.03.006.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1324_CR9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1053\/j.gastro.2018.06.031","volume":"155","author":"G Musso","year":"2018","unstructured":"Musso G, Cassader M, Paschetta E, Gambino R. Bioactive lipid species and metabolic pathways in progression and resolution of nonalcoholic steatohepatitis. Gastroenterology. 2018;155:282-302.e8. https:\/\/doi.org\/10.1053\/j.gastro.2018.06.031.","journal-title":"Gastroenterology"},{"issue":"16","key":"1324_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612748","volume":"24","author":"M Vitulo","year":"2023","unstructured":"Vitulo M, Gnodi E, Rosini G, Meneveri R, Giovannoni R, Barisani D. Current therapeutical approaches targeting lipid metabolism in NAFLD. Int J Mol Sci. 2023;24(16):12748. https:\/\/doi.org\/10.3390\/ijms241612748.","journal-title":"Int J Mol Sci"},{"issue":"53","key":"1324_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43042-023-00433-x","volume":"24","author":"SM Samarasinghe","year":"2023","unstructured":"Samarasinghe SM, Hewage AS, Siriwardana RC, Tennekoon KH, Niriella MA, De Silva S. Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicity. Egypt J Med Hum Genet. 2023;24(53):1\u201314. https:\/\/doi.org\/10.1186\/s43042-023-00433-x.","journal-title":"Egypt J Med Hum Genet"},{"issue":"1","key":"1324_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","volume":"22","author":"V Manne","year":"2018","unstructured":"Manne V, Handa P, Kowdley KV. Pathophysiology of Nonalcoholic Fatty Liver Disease\/Nonalcoholic Steatohepatitis. Clin Liver Dis. 2018;22(1):23\u201337. https:\/\/doi.org\/10.1016\/j.cld.2017.08.007.","journal-title":"Clin. Liver Dis"},{"issue":"3","key":"1324_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.24875\/hgmx.20000088","volume":"83","author":"D Vidal-Gonz\u00e1lez","year":"2020","unstructured":"Vidal-Gonz\u00e1lez D, Uribe M. Assessment of non-alcoholic fatty liver disease by non-invasive methods: present and future perspectives. Rev Med Hosp Gen Mex. 2020;83(3):135\u201343. https:\/\/doi.org\/10.24875\/hgmx.20000088.","journal-title":"Rev Med Hosp Gen Mex"},{"key":"1324_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.803244","volume":"12","author":"J Vandooren","year":"2021","unstructured":"Vandooren J, Itoh Y. Alpha-2-Macroglobulin in inflammation, immunity and infections. Front Immunol. 2021;12:803244. https:\/\/doi.org\/10.3389\/fimmu.2021.803244.","journal-title":"Front Immunol"},{"issue":"7","key":"1324_CR15","first-page":"1789","volume":"20","author":"N Kawada","year":"2014","unstructured":"Kawada N, Kim YK. Role of alpha-2-macroglobulin in fibrosis and inflammation in NAFLD. World J Gastroenterol. 2014;20(7):1789\u201399.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1324_CR16","first-page":"1004","volume":"67","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Liu X. Alpha-2-macroglobulin inhibits hepatic stellate cell activation and attenuates fibrosis in experimental liver injury models. Hepatology. 2018;67(3):1004\u201317.","journal-title":"Hepatology"},{"issue":"3","key":"1324_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/metabo14030153","volume":"14","author":"S Rafaqat","year":"2024","unstructured":"Rafaqat S, Gluscevic S, Mercantepe F, Rafaqat S, Klisic A. Interleukins: pathogenesis in non-alcoholic fatty liver disease. Metabolites. 2024;14(3):153. https:\/\/doi.org\/10.3390\/metabo14030153.","journal-title":"Metabolites"},{"key":"1324_CR18","doi-asserted-by":"publisher","unstructured":"Flisiak-Jackiewicz M, Bobrus-Chociej A, Taras\u00f3w E, Wojtkowska M, BiaBokoz-Kalinowska, Lebensztejn DM. Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children. Can J Gastroenterol Hepatol. 2018; 2018 (1): 1\u20139. https:\/\/doi.org\/10.1155\/2018\/3870454","DOI":"10.1155\/2018\/3870454"},{"key":"1324_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1081334","volume":"14","author":"C Song","year":"2023","unstructured":"Song C, Long X, He J, Huang Y. Recent evaluation about inflammatory mechanisms in nonalcoholic fatty liver disease. Front Pharmacol. 2023;14:1081334. https:\/\/doi.org\/10.3389\/fphar.2023.1081334.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1324_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10030699","volume":"10","author":"O Deckmyn","year":"2022","unstructured":"Deckmyn O, Poynard T, Bedossa P, Paradis V, Peta V, Pais R, et al. Clinical interest of serum alpha-2 macroglobulin, apolipoprotein A1, and haptoglobin in patients with non-alcoholic fatty liver disease, with and without type 2 diabetes, before or during COVID-19. Biomedicines. 2022;10(3):699.","journal-title":"Biomedicines"},{"key":"1324_CR21","unstructured":"International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Brussels: International Diabetes Federation. 2006. Available from: https:\/\/www.idf.org\/"},{"issue":"5","key":"1324_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KGMM Alberti","year":"2006","unstructured":"Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469\u201380. https:\/\/doi.org\/10.1111\/j.1464-5491.2006.01858.x.","journal-title":"Diabet Med"},{"issue":"3","key":"1324_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/cld.1022","volume":"17","author":"T Kohut","year":"2021","unstructured":"Kohut T, Panganiban J. Lifestyle intervention as the primary treatment for pediatric nonalcoholic fatty liver disease. Clin Liver Dis. 2021;17(3):185\u201390. https:\/\/doi.org\/10.1002\/cld.1022.","journal-title":"Clin Liver Dis"},{"key":"1324_CR24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/jama.2018.20579","volume":"321","author":"JB Schwimmer","year":"2019","unstructured":"Schwimmer JB, Ugalde-Nicalo P, Welsh JA, Angeles JE, et al. Effect of a low free sugar diet vs usual diet on nonalcoholic fatty liver disease in adolescent boys: a randomized clinical trial. JAMA. 2019;321:256\u201365. https:\/\/doi.org\/10.1001\/jama.2018.20579.","journal-title":"JAMA"},{"key":"1324_CR25","unstructured":"Egypt demographic and health survey 2022. Cairo, Egypt and, Rockville. Maryland, USA: Ministry of Health and Population, El-Zanaty and Associates, and ICF."},{"issue":"1","key":"1324_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.11152\/mu-3815","volume":"25","author":"KA Kang","year":"2023","unstructured":"Kang KA, Lee SR, Jun DW, Do IG, Kim MS. Diagnostic performance of a novel ultrasound-based quantitative method to assess liver steatosis in histologically identified nonalcoholic fatty liver disease. Med Ultrason. 2023;25(1):7\u201313. https:\/\/doi.org\/10.11152\/mu-3815.","journal-title":"Med Ultrason"},{"issue":"6","key":"1324_CR27","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004.","volume":"64","author":"European Association for the Study of the Liver (EASL)","year":"2016","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388\u2013402. https:\/\/doi.org\/10.1016\/j.jhep.2015.11.004.","journal-title":"J Hepatol"},{"issue":"7","key":"1324_CR28","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999-2014.e1. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.312.","journal-title":"Gastroenterology"},{"issue":"5","key":"1324_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/life15050696","volume":"15","author":"TO Karahan","year":"2025","unstructured":"Karahan TO, Akyuz EY, Karadag DY, Yilmaz Y, Eren F. Effects of intermittent fasting on liver steatosis and fibrosis, serum FGF-21 and autophagy markers in metabolic dysfunction-associated fatty liver isease: a randomized controlled trial. Life. 2025;15(5):696. https:\/\/doi.org\/10.3390\/life15050696.","journal-title":"Life"},{"key":"1324_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/pst.185","volume":"4","author":"SA Julious","year":"2005","unstructured":"Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4:287\u201391. https:\/\/doi.org\/10.1002\/pst.185.","journal-title":"Pharm Stat"},{"key":"1324_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s40608-017-0158-0","volume":"4","author":"B Sebo","year":"2017","unstructured":"Sebo B, Herrman FR, Haller DM. Accuracy of anthropometric measurements by general practitioners in overweight and obese patients. BMC Obes. 2017;4:23. https:\/\/doi.org\/10.1186\/s40608-017-0158-0.","journal-title":"BMC Obes"},{"issue":"151","key":"1324_CR32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1039\/an9729700142","volume":"97","author":"D Barham","year":"1972","unstructured":"Barham D, Trinder P. An improved colour for the determination of blood glucose by oxidase system reagent. Analyst. 1972;97(151):142\u20135. https:\/\/doi.org\/10.1039\/an9729700142.","journal-title":"Analyst"},{"key":"1324_CR33","first-page":"1127","volume":"39","author":"J Seidel","year":"1993","unstructured":"Seidel J, Klos S, Ziegenhorn T. AACC meeting abstract 34. Clin Chem. 1993;39:1127.","journal-title":"Clin Chem"},{"issue":"3","key":"1324_CR34","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/clinchem\/44.3.522","volume":"44","author":"H Sugiuchi","year":"1998","unstructured":"Sugiuchi H, Uji Y, Okabe H, Irie T, Uekama K, Kayahara N, Miyauchi K. Direct measurement of low-density lipoprotein cholesterol in serum with polyvinyl sulfate\u2013polyethylene glycol\u2013modified enzymes and surfactants. Clin Chem. 1998;44(3):522\u201331. https:\/\/doi.org\/10.1093\/clinchem\/44.3.522.","journal-title":"Clin Chem"},{"issue":"1","key":"1324_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0022-2275(20)41577-9","volume":"19","author":"GR Wornick","year":"1978","unstructured":"Wornick GR, Albers JJ. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res. 1978;19(1):65\u201376.","journal-title":"J Lipid Res"},{"issue":"15","key":"1324_CR36","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.4103\/0366-6999.161343","volume":"128","author":"K Han","year":"2015","unstructured":"Han K, Cho D, Kim Y, Kim K. Serum gamma glutamyl transferase concentration within the reference range is related to the coronary heart disease risk prediction in Korean men: analysis of the Korea National Health and Nutrition Examination Survey. Chin Med J. 2015;128(15):2006\u201311. https:\/\/doi.org\/10.4103\/0366-6999.161343.","journal-title":"Chin Med J"},{"key":"1324_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00289","volume":"4","author":"CA Dinarello","year":"2013","unstructured":"Dinarello CA, Novick D, Kim S, Kaplanski G. Interleukin-18 and IL-18 binding protein. Front Immunol. 2013;4:289. https:\/\/doi.org\/10.3389\/fimmu.2013.00289.","journal-title":"Front Immunol"},{"issue":"7","key":"1324_CR38","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/art.38576","volume":"66","author":"S Wang","year":"2014","unstructured":"Wang S, Wei X, Zhou J, Zhang J, Li K, et al. Identification of \u03b12-macroglobulin as a master inhibitor of cartilage-degrading factors that attenuates the progression of posttraumatic osteoarthritis. Arthritis Rheumatol. 2014;66(7):1843\u201353. https:\/\/doi.org\/10.1002\/art.38576.","journal-title":"Arthritis Rheumatol"},{"key":"1324_CR39","unstructured":"Nutri survey. (2007). Nutrition Survey and Calculation Guidelines, Software and additional Information for Windows \u2013 Cop (2007) (Last page modification: April 2nd, 2010. Dr. Juergan Ethardt \u2013 SEAMEO-TROPMEP. RCCN-University of Indonesia. www.nutrisurvey.de\/ena\/ena.html"},{"key":"1324_CR40","doi-asserted-by":"publisher","unstructured":"Mahfouz EM, Mohammed ES, Alkilany SF, Abdel Rahman TA. The relationship between dietary intake and stunting among pre-school children in Upper Egypt. Public Health Nutrition; 2021. https:\/\/doi.org\/10.1017\/S1368980021003656.","DOI":"10.1017\/S1368980021003656"},{"issue":"15","key":"1324_CR41","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.4236\/fns.2015.615147","volume":"6","author":"M Zaki","year":"2015","unstructured":"Zaki M, Hussein L, Gouda M, Bassuoni R, Hassanein A. Nutritional epidemiological study to estimate usual intake and to define optimum nutrient-profiling choice in the diet of Egyptian youths. Food Nutr Sci. 2015;6(15):1387\u201399. https:\/\/doi.org\/10.4236\/fns.2015.615147.","journal-title":"Food Nutr Sci"},{"issue":"B","key":"1324_CR42","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3889\/oamjms.2021.5663","volume":"02","author":"SM El Shebini","year":"2021","unstructured":"El Shebini SM, Essa HA, Moaty MIA, Ahmed MH, Hussein AMS, Mohamed MS, Tapozada ST. Serum Level of Uromdulin as an early predictor of kidney disorders. OA Maced J Med Sci. 2021;02(B):167\u201375. https:\/\/doi.org\/10.3889\/oamjms.2021.5663.","journal-title":"OA Maced J Med Sci"},{"key":"1324_CR43","volume-title":"Food Composition Tables for Egypt","author":"National Nutrition Institute","year":"2006","unstructured":"National Nutrition Institute. Food Composition Tables for Egypt. 2nd ed. Cairo (ARE): National Nutrition Institute; 2006.","edition":"2nd ed"},{"issue":"3","key":"1324_CR44","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3945\/ajcn.113.063602","volume":"98","author":"PE Miller","year":"2013","unstructured":"Miller PE, Cross AJ, Subar AF, Krebs-Smith SM, Park Y, Powell-Wiley T, Hollenbeck A, Reedy J. Comparison of 4 established DASH diet indexes: examining associations of index scores and colorectal cancer. Am J Clin Nutr. 2013;98(3):794\u2013803. https:\/\/doi.org\/10.3945\/ajcn.113.063602.","journal-title":"Am J Clin Nutr"},{"key":"1324_CR45","unstructured":"RDA (Recommended Daily Allowance) source. World Health Organization (WHO) & Food and Agriculture Organization of the United Nations (FAO). Vitamin and mineral requirements in human nutrition: Report of a joint FAO\/WHO expert consultation, 2nd edition. Geneva: World Health Organization, 2004."},{"issue":"17","key":"1324_CR46","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735\u201352. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.169404.","journal-title":"Circulation"},{"issue":"96","key":"1324_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-024-01630-4","volume":"24","author":"F Najafi","year":"2024","unstructured":"Najafi F, Pasdar Y, Nazar MM, Darbandi M. Association between obesity phenotypes and non-alcoholic fatty liver: a large population- based study. BMC Endocr Disord. 2024;24(96):1\u201311. https:\/\/doi.org\/10.1186\/s12902-024-01630-4.","journal-title":"BMC Endocr Disord"},{"issue":"7","key":"1324_CR48","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","volume":"110","author":"P Kasper","year":"2021","unstructured":"Kasper P, Martin A, Lang S, Kutting F, Goeser T, Demir M, et al. NAFLD and cardiovascular diseases: a clinical review. Clin Res Cardiol. 2021;110(7):921\u201337. https:\/\/doi.org\/10.1007\/s00392-020-01709-7.","journal-title":"Clin Res Cardiol"},{"key":"1324_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101092","volume":"42","author":"A Deprince","year":"2020","unstructured":"Deprince A, Haas JT, Staels B. Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Mol Metab. 2020;42:101092. https:\/\/doi.org\/10.1016\/j.molmet.2020.101092.","journal-title":"Mol Metab"},{"issue":"3","key":"1324_CR50","doi-asserted-by":"publisher","first-page":"923","DOI":"10.4103\/jfmpc.jfmpc_243_18","volume":"8","author":"R Mansour-Ghanaei","year":"2019","unstructured":"Mansour-Ghanaei R, Mansour-Ghanaei F, Naghipour M, Farahnaz Joukar F. Biochemical markers and lipid profile in nonalcoholic fatty liver disease patients in the PERSIAN guilan cohort study (PGCS), Iran. J Family Med Prim Care. 2019;8(3):923\u20138. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_243_18.","journal-title":"J Family Med Prim Care"},{"issue":"1","key":"1324_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.9790\/0853-1601123337","volume":"16","author":"TMJ Santhoshakumari","year":"2017","unstructured":"Santhoshakumari TMJ, Radhika G, Kanagavalli P. A study of anthropometric and lipid profile parameters in non-alcoholic fatty liver disease patients attending a tertiary care hospital at Puducherry. IOSR J Dent Med Sci (IOSR-JDMS). 2017;16(1):33\u20137. https:\/\/doi.org\/10.9790\/0853-1601123337.","journal-title":"IOSR J Dent Med Sci (IOSR-JDMS)"},{"key":"1324_CR52","doi-asserted-by":"publisher","first-page":"85","DOI":"10.15171\/jcvtr.2017.14","volume":"9","author":"LR Cuenza","year":"2017","unstructured":"Cuenza LR, Razon TLJ, Dayrit JC. Correlation between severity of ultrasonographic nonalcoholic fatty liver disease and cardiometabolic risk among Filipino wellness patients. J Cardiovasc Thorac Res. 2017;9:85\u20139. https:\/\/doi.org\/10.15171\/jcvtr.2017.14.","journal-title":"J Cardiovasc Thorac Res"},{"key":"1324_CR53","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5455\/medarh.2014.68.22-26","volume":"68","author":"T Novakovic","year":"2014","unstructured":"Novakovic T, Mekic M, Smilic L, Smilic T, Ini\u0107-Kostic B, Jovicevic L, et al. Anthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by non-invasive diagnostic methods. Med Arch. 2014;68:22\u20136. https:\/\/doi.org\/10.5455\/medarh.2014.68.22-26.","journal-title":"Med Arch"},{"key":"1324_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-018-0843-6","volume":"18","author":"BD Pardhe","year":"2018","unstructured":"Pardhe BD, Shakya S, Bhetwal A, Mathias J, Khanal PR, Pandit R, et al. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal. BMC Gastroenterol. 2018;18:109. https:\/\/doi.org\/10.1186\/s12876-018-0843-6.","journal-title":"BMC Gastroenterol"},{"issue":"10","key":"1324_CR55","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1111\/jgh.16222","volume":"38","author":"Y Takahashi","year":"2023","unstructured":"Takahashi Y, Seko Y, Yamaguchi K, Takeuchi K, Yano K, Kataoka S, et al. Gamma-glutamyl transferase predicts pemafibrate treatment response in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2023;38(10):1743\u20139. https:\/\/doi.org\/10.1111\/jgh.16222.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"1324_CR56","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1089\/AID.2020.0177","volume":"37","author":"JH Sim","year":"2021","unstructured":"Sim JH, Sherman JB, Stanley TL, Corey KE, Fitch KV, Looby SE, et al. Pro-inflammatory interleukin-18 is associated with hepatic steatosis and elevated liver enzymes in people with HIV mono-infection. AIDS Res Hum Retroviruses. 2021;37(5):385\u201390. https:\/\/doi.org\/10.1089\/AID.2020.0177.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"22","key":"1324_CR57","doi-asserted-by":"publisher","first-page":"8602","DOI":"10.3390\/ijms21228602","volume":"21","author":"S Hohenester","year":"2020","unstructured":"Hohenester S, Kanitz V, Schiergens T, Einer C, Nagel J, Wimmer R, Reiter FP, Gerbes AL, De Toni EN, Bauer C, Holdt C, Mayr D, Rust C, Schnurr M, Zischka H, Geier A, Denk G. IL-18 But Not IL-1 Signaling Is Pivotal for the Initiation of Liver Injury in Murine Non-Alcoholic Fatty Liver Disease. Int J Mol Sci. 2020;21(22):8602. https:\/\/doi.org\/10.3390\/ijms21228602.","journal-title":"Int J Mol Sci"},{"key":"1324_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.919973","volume":"13","author":"SA Ihim","year":"2022","unstructured":"Ihim SA, Abubakar SD, Zian Z, Sasaki T, Saffarioun M, Maleknia S, et al. Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: biological role in induction, regulation, and treatment. Front Immunol. 2022;13:919973. https:\/\/doi.org\/10.3389\/fimmu.2022.919973.","journal-title":"Front Immunol"},{"issue":"1","key":"1324_CR59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","volume":"281","author":"CA Dinarello","year":"2018","unstructured":"Dinarello CA. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 2018;281(1):8\u201327. https:\/\/doi.org\/10.1111\/imr.12621.","journal-title":"Immunol Rev"},{"issue":"7835","key":"1324_CR60","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","volume":"587","author":"NC Henderson","year":"2020","unstructured":"Henderson NC, Rieder F, Wynn TA. Fibrosis: from mechanisms to medicines. Nature. 2020;587(7835):555\u201366. https:\/\/doi.org\/10.1038\/s41586-020-2938-9.","journal-title":"Nature"},{"issue":"2","key":"1324_CR61","volume":"20","author":"Q Wang","year":"2025","unstructured":"Wang Q, Li Y, Zhang H, Chen X, Liu J. Exploring the association between dietary indices and metabolic dysfunction-associated steatotic liver disease: a mediation analysis based on NHANES data. PLoS One. 2025;20(2):e0301234.","journal-title":"PLoS One"},{"issue":"3","key":"1324_CR62","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.annepidem.2016.12.003","volume":"27","author":"L Xu","year":"2017","unstructured":"Xu L, Jiang CQ, Lam TH, Zhang WS, Cheng KK, Thomas GN. Liver enzymes and incident diabetes in a Chinese population: the role of gamma-glutamyl-transferase as a mediator. Ann Epidemiol. 2017;27(3):204\u20139. https:\/\/doi.org\/10.1016\/j.annepidem.2016.12.003.","journal-title":"Ann Epidemiol"},{"issue":"1","key":"1324_CR63","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/jgh","volume":"39","author":"L Pan","year":"2024","unstructured":"Pan L, Zhang S, Wang X, Liu Y, Zhao M. Nutritional and inflammatory status in non-alcoholic fatty liver disease: a mediation analysis of lipid biomarkers. J Gastroenterol Hepatol. 2024;39(1):112\u201320. https:\/\/doi.org\/10.1111\/jgh.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"1324_CR64","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1017\/S1368980019002568","volume":"23","author":"ML Xiao","year":"2020","unstructured":"Xiao ML, Lin JS, Li YH, Liu M, Deng YY, Wang CY, et al. Adherence to the dietary approaches to stop hypertension (DASH) diet is associated with lower presence of non-alcoholic fatty liver disease in middle-aged and elderly adults. Public Health Nutr. 2020;23(4):674\u201382. https:\/\/doi.org\/10.1017\/S1368980019002568.","journal-title":"Public Health Nutr"},{"key":"1324_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-025-02710-7","author":"MM Elhoseeny","year":"2025","unstructured":"Elhoseeny MM, Rageh F, Bakry N, Elgamal R, Ahmed SS, Samar M, et al. Culturally adapted hypocaloric diet improves hepatic steatosis, inflammatory and oxidative biomarkers in Egyptian MASLD patients: a single-arm interventional study. Lipids Health Dis. 2025. https:\/\/doi.org\/10.1186\/s12944-025-02710-7.","journal-title":"Lipids Health Dis"}],"container-title":["Journal of Health, Population and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41043-026-01324-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-026-01324-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-026-01324-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T09:57:46Z","timestamp":1778493466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41043-026-01324-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1324"],"URL":"https:\/\/doi.org\/10.1186\/s41043-026-01324-8","relation":{},"ISSN":["2072-1315"],"issn-type":[{"value":"2072-1315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was ethically approved by the ethical committee of the Medical Research Institute of the National Research Centre (13050204-2).\u00a0All authors in the current research article confirm their participation as described in the authors contributions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"The publisher has the authors\u2019 permission to publish the research article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}